Capacity Builders Inc. Navajo Youth Builders Personal Responsibility Education Innovation Strategies Project

计划入组 834 人 · 首次发布于 2019 年 11 月 27 日

SQ-Kyrin TMVr FIM Study

计划入组 20 人 · 首次发布于 2021 年 9 月 10 日

Healthetech, Inc. SMART Study

计划入组 56 人 · 首次发布于 2005 年 9 月 19 日

Captisol enabled furosemide (SQ Innovation)

SQ-22031

SQ-29-548

SQ Innovation, Inc.

United States

Innovation Pharmaceuticals, Inc.

United States

GI Innovation, Inc.

South Korea

Ligand Pharmaceuticals Gains FDA Approval for Lasix ONYU Heart Failure Device, Driving 46% Share Price Surge

SQ Innovation Secures Series B Funding Following FDA Approval of Subcutaneous Furosemide for Heart Failure

SQ Innovation's Lasix ONYU Receives Tentative FDA Approval for Congestive Heart Failure Treatment